JC-virus (JCV) epidemiology in multiple sclerosis (MS) (JEMS)

Title
JC-virus (JCV) epidemiology in multiple sclerosis (MS) (JEMS)

Type of intervention
Drug, observational

Form of MS
All forms of MS

Brief summary
This study will estimate the prevalence of anti-JCV antibodies in MS patients. Prevalence of anti-JCV antibodies will be estimated as the number of patients with anti-JCV antibodies detected in serum divided by the total number of patients with a serum sample that was evaluated. Prevalence of anti-JCV antibodies will also be estimated by the criteria described in the protocol

Inclusion criteria
All patients with a diagnosis of MS of any type, irrespective of their treatment, are eligible to participate once.

Anticipated start date

Recruitment status
Closed

Recruitment contacts
See link below

Further details
http://clinicaltrials.gov/ct2/show/study/NCT01185717?term=multiple+sclerosis+australia&rank=18&show_locs=Y#locn

Region
WA, VIC

Trial results

Last updated: May 2011